A study demonstrated that E-, P- and L-selectins were all expressed on human peritoneal mesothelial cells and treatment with blocking antibodies for each of the adhesion molecules slowed the rate of adhesion of metastatic ovarian cancer cells under flow. This evidence concerns the gene SELL and ovarian carcinoma.